US2013064846A1PendingUtilityA1
Neisserial antigens
Est. expiryNov 6, 2017(expired)· nominal 20-yr term from priority
A61P 37/04C07K 14/22A61K 38/00A61P 43/00A61P 31/04A61K 39/00
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides proteins from Neisseria meningitidis (strains A & B) and from Neisseria gonorrhoeae , including amino acid sequences, the corresponding nucleotide sequences, expression data, and serological data. The proteins are useful antigens for vaccines, immunogenic compositions, and/or diagnostics.
Claims
exact text as granted — not AI-modified1 : An isolated protein comprising:
(a) the amino acid sequence of SEQ ID NO: 654; or (b) an amino acid sequence having 80% or greater sequence identity to the amino acid sequence of SEQ ID NO: 654; or (b) a fragment of SEQ ID NO: 654 of at least 10 contiguous amino acids in length.
2 : The isolated protein of claim 1 comprising (b).
3 : The isolated protein of claim 2 , wherein the amino acid sequence has 90% or greater sequence identity to the amino acid sequence of SEQ ID NO: 654.
4 : The isolated protein of claim 2 , wherein the amino acid sequence has 95% or greater sequence identity to the amino acid sequence of SEQ ID NO: 654.
5 : The isolated protein of claim 1 comprising (c).
6 : A composition comprising the protein of any one of claims 1 - 5 and an adjuvant.
7 : The composition of claim 6 further comprising a pharmaceutically acceptable carrier.Join the waitlist — get patent alerts
Track US2013064846A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.